| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.12 | 0.4 |